Catherine A. Knupp has sold ZTS and made no open-market buys since Aug 2018

Dr. Catherine A. Knupp, DVM, MS is a corporate insider and senior pharmaceutical executive known for her long tenure at Zoetis Inc. (NYSE: ZTS), where she served as Executive Vice President and President of Research & Development and was part of the company’s original executive team when Zoetis was established in 2013.( At Zoetis she led the establishment and global expansion of the company’s R&D organization, overseeing innovation in animal health and serving as a key member of the leadership team until her retirement from the role at the end of 2021, after which she continued as an advisor during the transition of R&D leadership.( Her leadership and mentoring contributions to the animal health industry have been recognized through honors such as Zoetis’ Feather in Her Cap Award and the creation of the AAVMC Dr. Catherine A. Knupp Scholarship, which highlights her impact on veterinary research and education.(

Before joining Zoetis, Knupp held a series of senior R&D positions in both human and animal health, including Vice President of Veterinary Medicine, Research & Development and earlier executive roles at Pfizer Animal Health, as well as human health research leadership roles at Bristol-Myers Squibb over a 35-year industry career.( She holds a BS in Chemistry from Western Illinois University and earned her DVM and MS in Veterinary Medicine and Toxicology from the University of Illinois at Urbana–Champaign, credentials that underpin her work in pharmacokinetics, toxicology, and translational animal health research.( Following her retirement from Zoetis, she has remained active in the field as Chief Scientific Officer at Dechra and as owner of Animal Health Innovations Consulting LLC, continuing to guide innovation and strategy in animal health.(

Written by Perplexity from public sources.